fda compounding semaglutide news september 2025

fda compounding semaglutide news september 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Novo's Wegovy and Ozempic removed

Name: fda compounding semaglutide news september 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Novo's Wegovy and Ozempic removed
Brand: aeroscroll.com
SKU: 34898480674
Price: 23.77 USD
Availability: InStock
Rating: 4.817200000000001 (6 reviews)

SKU: 34898480674

4.8

USD23.77 USD71.77

Pay in 4 interest-free payments of $5.94 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Safe for use in MDR1 deficient breeds

Not only has the Food and Drug Administration (FDA) fielded thousands of complaints tied to less expensive, compounded versions, but a 2026 Yale secret-shopper study found many online sellers of affordable GLP-1 drugs skip basic safety steps before prescribing